在当今全球化的商业环境中,专利战已成为企业间竞争的一种常见手段。最近,艾伯维与百济神州之间的专利纠纷,以及美敦力与Axonics的专利争议,都引起了业界的广泛关注。今年9月,艾伯维对百济神州提起诉讼,指控后者的BTK嵌合式降解激活化合物BGB-16673侵犯了其商业秘密。艾伯维声称,百济神州通过“诱使和鼓励”艾伯维的科学家刘华青跳槽,并带走了相关专利,利用这些信息加速了BGB-16673的开发,而...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.